New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion-Reference-Cited by-同舟云学术

New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion

Published:2019-01-09 Issue:9 Volume:25 Page:2070-2085
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Farino Zachary J.,Morgenstern Travis J.,Maffei Antonella,Quick Matthias,De Solis Alain J.,Wiriyasermkul Pattama,Freyberg Robin J.,Aslanoglou Despoina,Sorisio Denise,Inbar Benjamin P.,Free R. Benjamin,Donthamsetti Prashant,Mosharov Eugene V.,Kellendonk Christoph,Schwartz Gary J.^ORCID,Sibley David R.,Schmauss Claudia,Zeltser Lori M.,Moore Holly,Harris Paul E.,Javitch Jonathan A.,Freyberg Zachary^ORCID

Funder

U.S. Department of Defense

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

Pittsburgh Foundation

U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health

U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

National Alliance for Research on Schizophrenia and Depression

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

http://www.nature.com/articles/s41380-018-0344-6.pdf

Reference87 articles.

1. Fleischhacker WW, Siu CO, Boden R, Pappadopulos E, Karayal ON, Kahn RS et al. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial. Int J Neuropsychopharmacol. 2013;16:987–95.

2. Fabrazzo M, Monteleone P, Prisco V, Perris F, Catapano F, Tortorella A, et al. Olanzapine is faster than haloperidol in inducing metabolic abnormalities in schizophrenic and bipolar patients. Neuropsychobiology. 2015;72:29–36.

3. Freyberg Z, Aslanoglou D, Shah R, Ballon JS. Intrinsic and antipsychotic drug-induced metabolic dysfunction in schizophrenia. Front Neurosci. 2017;11:432.

4. Rajkumar AP, Horsdal HT, Wimberley T, Cohen D, Mors O, Borglum AD, et al. Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: a Danish population-based cohort study. Am J Psychiatry. 2017;174:686–94.

5. Karam CS, Ballon JS, Bivens NM, Freyberg Z, Girgis RR, Lizardi-Ortiz JE, et al. Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends Pharmacol Sci. 2010;31:381–90.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine-mediated autocrine inhibition of insulin secretion;Molecular and Cellular Endocrinology;2024-10

2. Dopamine in the regulation of glucose and lipid metabolism: a narrative review;Obesity;2024-07-30

3. Chronic pharmacologic manipulation of dopamine transmission ameliorates metabolic disturbance in Trappc9-linked brain developmental syndrome;JCI Insight;2024-06-18

4. Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia;Diabetes;2024-06-13

5. Regulatory roles of dopamine D2 receptor in milk protein production and apoptosis in mammary epithelial cells;Experimental Cell Research;2024-06